NSG BioLabs

What NSG BioLabs does

NSG BioLabs (legal entity NSG Bio Global Pte. Ltd., operating as NSG Bio) is a Singapore-based operator of BSL-2 certified co-working laboratory and office infrastructure serving biotech companies. Founded in 2019 by Daphne Teo, the company operates four locations across Singapore's premier biomedical clusters (three at Biopolis and NSG BioSuites at Geneo in Singapore Science Park), totaling approximately 70,000 sq ft with more than 400 shared equipment items. Its core offering is turnkey, move-in-ready wet-lab and office space with HEPA-filtered HVAC, dedicated tissue culture and microbiology rooms, regulatory compliance support, and a curated ecosystem of preferred partners (Amgen, Merck, Thermo Fisher, Charles River, Eppendorf, GenScript, Twist Bioscience, Bio-Rad and others). Resident companies span early-stage biotech startups, growing mid-stage companies, multinational corporate R&D outposts (e.g., POLA Chemical Industries), and academic researchers.

The business model is primarily recurring monthly rental of bench space and private lab suites, supplemented by preferred-partner arrangements with consumables and equipment vendors that yield incremental revenue or cost savings passed to residents. Pricing is quote-based and not publicly disclosed. Go-to-market combines direct enterprise sales via a Business Development team with community-led pipeline development through the NSG Bio Tomorrow sponsorship/grant program and the Amgen X NSG Golden Ticket Programme. In May 2024, NSG Bio closed a US$14.5 million round led by Celadon Partners with ClavystBio participation to fund facility expansion and ecosystem development, and has continued to add strategic partnerships through 2025-2026 with Merck, Thermo Fisher, and Charles River Laboratories among others.

Name

NSG BioLabs

Legal name

NSG Bio Global Pte. Ltd.

Website

https://nsgbio.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

NSG BioLabs operates Singapore's largest BSL-2 certified biotech co-working laboratory network, providing turnkey wet-lab and office infrastructure across four sites in Biopolis and Singapore Science Park to early-stage startups, growing biotechs, and multinational R&D outposts.

Ownership category

akta.pro rank

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory and Office Space Rental: NSG Bio generates revenue through rental of BSL-2 certified laboratory benches, private laboratory suites, and office spaces. The flexible rental system allows residents to scale their space requirements as their needs grow, with options ranging from individual benches to private lab suites.
2. Preferred Partner Services: Revenue generated through preferred partnership arrangements with equipment and consumables suppliers, where resident companies receive preferred rates and NSG Bio benefits from vendor partnerships.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

NSG BioLabs provides BSL-2 certified wet-laboratory and office co-working spaces for biotech startups, growing biotech companies, and multinational corporations across four Singapore locations totaling 70,000 sq ft with 400+ shared equipment items. The company operates NSG BioLabs @ Biopolis (three scalable facilities) and NSG BioSuites @ Geneo (private lab suites), complemented by the NSG Bio Tomorrow sponsorship and grant program for early-stage biotech companies. Revenue is generated primarily through recurring monthly rentals of laboratory benches, private lab suites, and office space, with value-added preferred partner services.

Product overview

NSG BioLabs operates as a biotech co-working laboratory and office space provider offering certified BSL-2 wet-laboratory facilities. The product portfolio consists of NSG BioLabs @ Biopolis (three scalable co-working laboratory facilities with shared equipment and private suites), NSG BioSuites @ Geneo (private laboratory suites - the largest site and newest product), and NSG Bio Tomorrow (sponsorship and grant programme for early-stage companies including the Amgen X NSG Golden Ticket Programme). The company provides turnkey laboratory infrastructure with over 400 equipment, research support, and proximity to Singapore's biomedical ecosystem at Biopolis.

Differentiator

Problem solved

Functional benefit

Brands

• NSG Bio Tomorrow: A sponsorship and grant programme for early-stage biotech companies, providing cash grants, lab credits, mentorship, and access to investors.
• NSG BioSuites

Products and services

• NSG BioLabs @ Biopolis Three scalable BSL-2 certified wet-laboratory and office co-working spaces at Singapore's Biopolis biomedical hub, offering state-of-the-art technology, dedicated research rooms for tissue culture and microbiological work, over 400 shared equipment items, and options ranging from individual benches to private laboratory suites. Designed for early-stage and growing biotech startups, as well as multinational corporations establishing Singapore R&D operations.
• NSG BioSuites @ Geneo Private laboratory suites product launched at the Geneo development in Singapore Science Park (in partnership with CapitaLand). Offers small to large affordable private lab suites purpose-built for biotech companies seeking dedicated, scalable spaces with shared equipment and research facilities. Targeted at growing biotech companies and multinationals requiring private dedicated lab space beyond bench rentals.
• NSG Bio Tomorrow Sponsorship and Grant Programme Sponsorship and grant programme for early-stage biotech companies, providing cash grants or lab credits at NSG BioLabs, mentorship from world-renowned advisors, and opportunities to pitch to sponsors and investors. Acts as a funnel to identify and nurture promising startups who may become long-term residents.
• Amgen X NSG Golden Ticket Programme Sponsored programme with Amgen awarding one promising biotech startup per year with one year of free lab space (one bench for one scientist, one office desk, one freezer, one fridge), plus mentorship access to Amgen's network of industry leaders. Serves as a pipeline and awareness-building mechanism for NSG Bio's lab space offerings.

Quantifiable outcome

• Significant cost reduction compared to building and maintaining own lab infrastructure
• +3 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

15 partnerships are on record, tiered core and preferred.

• Charles River LaboratoriescoreTechnology or Integration · 1 April 2026Signed Memorandum of Understanding to collaborate on supporting biotech companies and fostering innovation. Partnership leverages NSG Bio's infrastructure and Charles River's scientific expertise to assist life sciences companies from research to development milestones.
• Proteintech SingaporepreferredTechnology or Integration · 1 March 2026Preferred partnership formalizing collaboration to support resident companies with Proteintech's antibody products and research tools.
• Global Cold Chain Solutions (GCCS)preferredTechnology or Integration · 1 March 2026Partnership with Global Cold Chain Solutions Pte Ltd to support residents with cold chain logistics and storage solutions for temperature-sensitive biological materials.
• Bio-Rad LaboratoriespreferredTechnology or Integration · 1 February 2026Preferred partnership providing access to Bio-Rad's laboratory equipment and products for NSG Bio residents with preferred pricing.
• ITS Science & MedicalpreferredTechnology or Integration · 1 December 2025Preferred partnership with ITS SCIENCE & MEDICAL PTE LTD providing laboratory supplies and services to NSG Bio residents.
• Twist BiosciencepreferredTechnology or Integration · 1 October 2025Memorandum of Understanding signed to strengthen innovation through partnership, providing NSG Bio residents access to Twist's synthetic DNA solutions.
• Integrated DNA Technologies (IDT)preferredTechnology or Integration · 1 June 2025Preferred partnership to empower NSG Bio's community of biotech companies with IDT's oligonucleotide and CRISPR products and services.
• Thermo Fisher ScientificcoreTechnology or Integration · 1 April 2025Strategic Memorandum of Understanding to strengthen Singapore's biotech startup ecosystem. Thermo Fisher provides scientific expertise and resources to support NSG Bio residents.
• GenScriptcoreTechnology or Integration · 1 January 2025Preferred partnership with global leader in synthetic biology, providing NSG Bio residents access to GenScript's CRISPR, gene synthesis, and other biotech services.
• Eppendorf GrouppreferredTechnology or Integration · 1 June 2024Partnership to support biotech companies in Singapore. Eppendorf provides preferred rates for consumables and services to NSG Bio residents.
• Enterprise SingaporecoreStrategic or Co-development Partner · 1 May 2024Government agency partnership supporting biotech startups and innovation in Singapore. Enterprise Singapore provides backing and support for NSG Bio's ecosystem development.
• Merck GroupcoreStrategic or Co-development Partner · 1 May 2024Strategic partnership with Merck Group to support biotech startups and innovation. Merck provides guidance, mentorship, and access to expertise for resident companies. Entering second year of preferred partnership in 2025.
• AmgencoreStrategic or Co-development PartnerSponsor of the Amgen X NSG Golden Ticket Programme, awarding promising startups with free lab space and mentorship. Amgen provides access to their network of industry leaders for guidance and mentorship.
• A*STAR Research Support CenterpreferredTechnology or IntegrationA*STAR's Research Support Center provides preferred rates for consumables and services to NSG Bio residents, supporting cost-efficient research operations.
• CapitaLandcoreStrategic or Co-development PartnerPartnership with CapitaLand and The Work Project for the Geneo development, combining real estate expertise with NSG Bio's lab space experience for the NSG BioSuites launch.

Scale indicators6 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• LabCentral: Cambridge, Massachusetts-based nonprofit operator of co-working laboratory and office facilities for early-stage biotech startups. Operates a similar shared-equipment, BSL-grade lab model targeted at resident biotech companies, and is one of the most established global comparables for NSG Bio's co-working laboratory concept.
• MBC BioLabs: South San Francisco-based biotech co-working laboratory operator providing turnkey lab space, shared equipment, and programming for early-stage life sciences startups. Closely comparable to NSG Bio on the shared-lab, equipment-bundled, biotech-tenant business model.
• BioLabs: Operator of co-working laboratory and office facilities across multiple U.S. and European cities, now affiliated with CBRE. Provides fully equipped lab space, shared equipment, and entrepreneurial programming for resident biotech startups, making it a direct global comparable to NSG Bio's co-working model.
• Johnson & Johnson Innovation JLABS: Global network of pharma-sponsored biotech incubators providing no-strings-attached lab space, equipment, and mentorship to early-stage life sciences companies. Comparable to NSG Bio's Amgen and Merck partnership-driven model and Golden Ticket programs.
• Bayer Co.Lab: Pharma-sponsored biotech incubator providing shared lab infrastructure, mentorship, and ecosystem access to early-stage life sciences companies across multiple geographies. Closely comparable to NSG Bio's partnership-driven, sponsor-funded incubator model.
• Illumina Accelerator: Genomics-focused startup accelerator providing lab access, mentorship, and sequencing infrastructure for early-stage genomics and biotech companies. Comparable to NSG Bio on the accelerator-meets-lab-space model with strong sponsor backing.
• IndieBio: Global biotech accelerator (part of SOSV) providing lab access, mentorship, and seed funding to early-stage biology startups across multiple locations. Comparable to NSG Bio on the early-stage biotech programming and lab access model.
• Petri: Boston-based biotech startup platform providing early-stage biotech founders with lab access, community, and resources. Comparable to NSG Bio on the early-stage biotech support and lab infrastructure model, though at smaller scale.

Others

• A*STAR: Singapore government Agency for Science, Technology and Research, which operates the Biopolis biomedical research campus where NSG Bio's first sites are located. Relevant as the dominant public-sector ecosystem player in the same Singapore biotech hub that NSG Bio serves.
• SGInnovate: Singapore government-linked deep tech investor and ecosystem builder focused on life sciences and other frontier technologies. Relevant as a parallel ecosystem builder in Singapore that shares some target founders and investor networks with NSG Bio, though it does not provide laboratory space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nsg-biolabs/?originalSubdomain=sg
• Instagraminstagram.com/nsgbiolabs/?hl=en

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NSG BioLabs